Invesaro

Stocks TXRH Financial statements

Financial statements

Texas Roadhouse, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Texas Roadhouse, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,9912,2202,4572,7562,3983,4644,0154,6325,3735,878
Cost of revenue2,2602,1152,8573,3613,897
Gross profit496284607654735
Selling and marketing13.314.517.118.313.821.12528.331.835.1
General and administrative111123136149120157173198223227
Operating income17218618821223.8297320354517475
Interest expense1.261.58
Pre-tax income17218618921419.3293321358524481
Income tax51.248.624.332.4-15.739.643.744.680.166.4
Net income to minority interests4.986.016.077.073.678.027.788.810.88.78
Net income11613215817431.3245270305434406
EBITDA255280289328142424457507695681
EPS, basic1.641.852.212.470.453.523.994.566.506.11
EPS, diluted1.631.842.202.460.453.503.974.546.476.10
Shares, basic (weighted)70.47171.570.569.469.767.666.966.866.3
Shares, diluted (weighted)71.171.57270.969.970.167.967.16766.5
Dividend per share0.760.841.001.200.361.201.842.202.442.72

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents113151210108363336174104245135
Receivables56.176.592.199.398.4161150175193215
Inventory16.116.318.820.322.431.63838.340.845.6
Other current assets13.4
Total current assets200257345248511564397356517451
Property, plant and equipment8309129571,0571,0891,1621,2701,4751,6181,804
Lease right-of-use assets500531578630694770880
Goodwill117121123125127127149170170242
Intangible assets3.622.71.961.232.271.525.613.481.2717.7
Other non-current assets29.537.742.453.36679.173.995116155
Total assets1,1801,3311,4691,9842,3252,5122,5262,7933,1913,549
Accounts payable50.857.662.161.76795.2106132145163
Accrued liabilities2629.734.239.75264.754.568.110297.4
Deferred revenue130157192209233301335374401449
Short-term debt0.170.0150
Total current liabilities280330385417506602652745828909
Long-term debt52.4522.081901005000
Lease liabilities539572623678743826943
Other non-current liabilities3442.150.465.510393.789.2115145192
Total liabilities4224795091,0521,3821,4381,4981,6361,8172,068
Total debt52.5522.082401005000
Paid-in capital22023725714114611513.10
Retained earnings5316026887767829449991,1421,3581,461
Other comprehensive income-0.19-0.04-0.23-0.23-0.110
Shareholders' equity7508399469169281,0581,0131,1421,3581,461
Minority interests8.0212.315.115.215.515.41515.815.420.9
Total equity7588519619319431,0731,0281,1581,3741,482
Total liabilities and equity1,1801,3311,4691,9842,3252,5122,5262,7933,1913,549
Shares outstanding70.671.271.669.469.669.46766.866.665.9

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income12113816418234.9253278314444414
Depreciation and amortization8393.5101116118127137153178207
Stock-based compensation26.126.93435.529.438.136.734.247.147.8
Deferred income tax5.99-5.0712.36.34-19.98.99.463.12-13.87.03
Change in receivables-10.7-20.4-15.6-5.771.06-62.411.1-24.4-17.7-21.3
Change in inventory-0.46-0.05-2.5-1.41-2.02-9.23-6.10.11-2.44-3.65
Cash from operations257286353374230469512565754730
Capital expenditures-165-162-156-214-154-201-246-347-354-388
Acquisitions-16.5-2.17-1.54-10.60-33.1-39.20-108
Purchases of investments00-4.18
Cash from investing-165-178-158-215-161-195-264-367-337-483
Stock issued2.671.56
Share buybacks-4.11-140-12.6-51.6-213-50-80-150
Dividends paid-52.1-58.2-68.6-102-25-83.7-124-147-163-180
Cash from financing-38.7-70.2-136-262186-301-410-267-276-358
Net change in cash53.63859.2-102255-27.5-162-69.6141-111
Free cash flow92.312519716076268266218399342
Interest paid1.011.220.90.743.893.191.551.120.890.98
Income taxes paid42.950.220.520.43.7839.825.939.987.375.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $159.75 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin7.7%Operating income / revenue.
EBITDA margin11.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin7.8%Pre-tax income / revenue.
Net margin6.6%Net income / revenue.
FCF margin6.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin12.9%Cash from operations / revenue.
Effective tax rate13.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)26.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)11.3%Net income / average total assets.
Return on invested capital (ROIC)29.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue6.4%Capital expenditures / revenue.
D&A / revenue3.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y13.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y19.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-8.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y14.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y81.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-1.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y14.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y36.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-6.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y14.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y67.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-5.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y15.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y68.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-3.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y12.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y25.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-14.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y8.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y35.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y11.5%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y13.9%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y49.8%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y12.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y8.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.0%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.46xCurrent assets / current liabilities.
Quick ratio0.35x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.26x(Cash + short-term investments) / current liabilities.
Debt / equity0.03xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets1.4%Total debt / total assets.
Liabilities / assets57.0%Total liabilities / total assets.
Net debt-$152.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.22xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$428.9MCurrent assets - current liabilities.
Goodwill and intangibles / assets8.2%(Goodwill + intangible assets) / total assets.
Tangible book value$1.26BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.70xRevenue / average total assets.
Fixed asset turnover3.30xRevenue / average property, plant and equipment.
Receivables turnover84.1xRevenue / average receivables.
Days sales outstanding4 days365 x average receivables / revenue.
FCF conversion98.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow49.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$6.27Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$94.53Revenue / diluted weighted shares.
FCF per share$6.16Free cash flow / diluted weighted shares.
Operating cash flow per share$12.19Cash from operations / diluted weighted shares.
Book value per share$23.76Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$19.17Tangible book value / shares outstanding.
Cash per share$3.09(Cash + short-term investments) / shares outstanding.
Payout ratio45.7%Dividends paid / net income, when net income is positive.
Dividends / FCF46.4%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF39.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$10.49BShare price x shares outstanding.
Enterprise value$10.33BMarket cap + total debt - cash - short-term investments.
P/E25.4xMarket cap / net income. Only when net income is positive.
P/S1.68xMarket cap / revenue.
P/B6.73xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.34xMarket cap / tangible book value, when positive.
P/FCF25.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF13.1xMarket cap / cash from operations, when positive.
EV/Sales1.66xEnterprise value / revenue.
EV/EBIT21.4xEnterprise value / operating income, when both are positive.
EV/EBITDA14.7xEnterprise value / EBITDA, when both are positive.
EV/FCF25.4xEnterprise value / free cash flow, when both are positive.
FCF yield3.9%Free cash flow / market cap.
Earnings yield3.9%Net income / market cap (the inverse of P/E).
Dividend yield1.8%Dividends paid over the period / market cap.
Shareholder yield3.3%(Dividends paid + share buybacks) / market cap.
PEG1.65xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Texas Roadhouse, Inc.'s revenue in fiscal 2025?

Texas Roadhouse, Inc. reported revenue of $5.88B for fiscal 2025, 9.4% higher than the year before.

Was Texas Roadhouse, Inc. profitable in fiscal 2025?

Yes. Net income was $405.6M, a net margin of 6.9%.

How much free cash flow did Texas Roadhouse, Inc. generate in fiscal 2025?

Cash from operations of $730.1M minus capital expenditures of $388.0M left free cash flow of $342.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Texas Roadhouse, Inc.